WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today informed shareholders about several differences between holding shares in Direct Registration System (“DRS”) accounts and holding them in brokerage accounts.
A DRS account is an alternative to using a brokerage account and Tevogen encourages shareholders to explore the differences. DRS accounts ensure your shares are registered directly in your name and not held through intermediary brokers, allowing shareholder to exercise direct control over their shares. DRS accounts may also have reduced transaction and account maintenance costs for shareholders. Brokerage accounts may provide greater access to tools, and selling shares in this type of account may be quicker when compared to a DRS account. Investors may also incur certain costs in connection with transferring shares in and out of a brokerage account.
For more information about these and other differences, please contact the Company’s transfer agent, Continental Stock Transfer & Trust.
Contacts
Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701
Communications@Tevogen.com
- Bessor Announces $125,000 Private Placement Financing and Provides Corporate Update - May 16, 2025
- Investors who lost money on NET Power, Inc.(NPWR) should contact Levi & Korsinsky about pending Class Action – NPWR - May 16, 2025
- Compass Group Diversified Holdings, LLC Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 8, 2025 to Discuss Your Rights – CODI - May 16, 2025
